Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919152 · ClinicalTrials.gov registry record
Economic Outcomes of Enteral and Parenteral Proton Pump Inhibitor (PPI) Use in the Intensive Care Unit (ICU)
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 534
- Enrollment target
NCT00919152 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 534 participants.
The verdict
NCT00919152 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 534 participants
- Enrollment target
Study Summary
This study will be a retrospective electronic medical chart review of all patients admitted to adult intensive care medicine units (ICU) at The Nebraska Medical Center over a three-year period from January 2006 through December 2008. The study will have three primary aims: * Aim 1: Determine correlates (qualifying criteria) of patients initiated on enteral versus parenteral PPIs as first choice in ICU and after discharge from ICU, * Aim 2: Based on correlates determine number of patients receiving parenteral PPIs that could receive enteral therapy as first choice in ICU and after discharge from ICU, * Aim 3: Estimate the potential savings in drug costs associated with conversion of eligible patients from parenteral to enteral PPI therapy with emphasis on lansoprazole solutab in the ICU and conversion of eligible patients requiring continued AST from parenteral to enteral PPI therapy after discharge from ICU.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2009-07-01 |
| Est. Completion | 2012-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00919152
The ClinicalTrials.gov registry entry for NCT00919152 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 534 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00919152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00919152 about?
NCT00919152 is a clinical study titled "Economic Outcomes of Enteral and Parenteral Proton Pump Inhibitor (PPI) Use in the Intensive Care Unit (ICU)". This study will be a retrospective electronic medical chart review of all patients admitted to adult intensive care medicine units (ICU) at The Nebraska Medical Center over a three-year period from January 2006 through December 2008. The study will have three primary aims: * Aim 1: Determine correl...
What is the current status of trial NCT00919152?
This trial is currently completed. The enrollment target is 534 participants. The study started on 2009-07-01. Estimated completion is 2012-01-01.
Who is sponsoring clinical trial NCT00919152?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.